Literature DB >> 3219236

HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response.

A Dalgleish1, J Richardson, E Matutes, K Cruickshank, A Newell, A Sinclair, R Thorpe, M Brasher, J Weber, D Catovsky.   

Abstract

All 17 patients with tropical spastic paraparesis (TSP) in a series seen in the United Kingdom have antibodies to the human T cell leukemia virus type 1 (HTLV-1). Cultured peripheral blood lymphocytes from these patients formed multinucleated giant cells and reacted with sera and monoclonal antibodies to HTLV-1 in a manner identical to adult T cell leukemia-lymphoma (ATLL) patient lymphocytes. Western blot analysis failed to reveal any marked difference in the antigens recognized by sera from TSP and ATLL patients. The sera from TSP patients, their asymptomatic relatives and ATLL patients were titrated using the following assays: enzyme-linked immunosorbent assays (ELISA), particle agglutination, antibody-dependent cell-mediated cytotoxicity, and pseudotype neutralization. There were significantly stronger serologic responses in the TSP patients than in their relatives or ATLL patients. High antibody titers in the presence of replicating virus often reflect the antigen load; however, these data are also consistent with the suggestion that neurologic damage in TSP may be immunologically mediated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219236     DOI: 10.1089/aid.1988.4.475

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  18 in total

1.  HLA profile and HTLV-I associated myelopathy (HAM/TSP) in Natal, South Africa.

Authors:  A I Bhigjee; P L Bill; M G Hammond; I M Windsor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

Review 2.  Does a retrovirally encoded superantigen cause multiple sclerosis?

Authors:  P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

3.  A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt.

Authors:  N T Constantine; M Fathi Sheba; A L Corwin; R S Danahy; J D Callahan; D M Watts
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

4.  Tropical spastic paraparesis and human T-cell lymphotropic virus type 1.

Authors:  P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

5.  Screening for prolonged incubation of HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis.

Authors:  J K Cruickshank; J H Richardson; O S Morgan; J Porter; P Klenerman; J Knight; A L Newell; P Rudge; A G Dalgleish
Journal:  BMJ       Date:  1990-02-03

6.  Methylprednisolone therapy in tropical spastic paraparesis.

Authors:  J Duncan; P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

7.  Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM).

Authors:  A Yoshioka; G Hirose; Y Ueda; Y Nishimura; K Sakai
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

8.  Human T cell leukaemia/lymphoma virus and blood donation.

Authors:  A G Dalgleish
Journal:  BMJ       Date:  1993-11-13

9.  Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis.

Authors:  A Ali; S Patterson; K Cruickshank; P Rudge; A G Dalgleish; S C Knight
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

10.  HTLV-I infection and neurological disease in Rio de Janeiro.

Authors:  A de Q Araujo; A Ali; A Newell; A G Dalgleish; P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.